Clinical Trial Update: Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS

View source ↗

Summary

Clinical trial update on scalable expanded access to ibudilast for amyotrophic lateral sclerosis. The study includes analysis of neurofilament levels and other …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• ibudilast (ibudilast)

Snippet

Sponsor: Mayo Clinic | Conditions: ALS | Status: AVAILABLE